SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-15-009020
Filing Date
2015-11-09
Accepted
2015-11-09 16:57:22
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1502540-10q.htm 10-Q 816874
2 EXHIBIT 31.1 t1502540-ex31_1.htm EX-31.1 6910
3 EXHIBIT 31.2 t1502540-ex31_2.htm EX-31.2 6892
4 EXHIBIT 32.1 t1502540-ex32_1.htm EX-32.1 2884
5 EXHIBIT 32.2 t1502540-ex32_2.htm EX-32.2 2788
  Complete submission text file 0001571049-15-009020.txt   3851815

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pahc-20150930.xml EX-101.INS 739712
7 XBRL SCHEMA FILE pahc-20150930.xsd EX-101.SCH 34249
8 XBRL CALCULATION FILE pahc-20150930_cal.xml EX-101.CAL 51803
9 XBRL DEFINITION FILE pahc-20150930_def.xml EX-101.DEF 105553
10 XBRL LABEL FILE pahc-20150930_lab.xml EX-101.LAB 285386
11 XBRL PRESENTATION FILE pahc-20150930_pre.xml EX-101.PRE 211997
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 151216454
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences